Changes in metabolites detected by proton magnetic resonance spectroscopy ((1)H MRS) of the brain have been demonstrated in Alzheimer's disease. Our objectives were, first, longitudinally to measure absolute concentrations of metabolites in both hippocampi, the sites of early Alzheimer's disease, in patients with clinical Alzheimer's disease and controls; secondly, to separate the relative contribution of atrophy and metabolite concentration change to overall signal change; and, thirdly, to d...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease.
If you are the owner of this record, you can report an update to it here: Report update to this record